Andreessen Horowitz

Venture Capital

Tier-1 venture capital firm with an active health tech portfolio. Investor in Pomelo Care Series C and Talkiatry Series D.

3

Deals Tracked

$432M

Disclosed Capital

Pediatric, Maternal

Segments

Deals

Date	Company	Round	Amount	Source
Q1 2026	Talkiatry	Series D	$210M	—
Q1 2026	Pomelo Care	Series C	$92M	—
Q2 2024	Talkiatry	Series C	$130M	—